Bisphosphonate-related Atypical Femoral Fracture with Bone Metastasis of Breast Cancer: Case Report and Review

作者：Hayashi Kazunori^*; Aono Masanari; Shintani Kousuke; Kazuki Kenichi

来源：Anticancer Research, 2014, 34(3): 1245-1249.

• Zoledronate
• atypical femoral fracture
• breast cancer
• bone metastasis

Background: Intravenous bisphosphonates (BPs) have been used to reduce the frequency of skeletal-related events due to bone metastases of several kinds of cancers. Although many studies on BP-related atypical fractures (BRAFs) due to the use of BP for osteoporosis treatment have been reported, few reports on BRAFs arising as a complication of long-term BP use for bone metastasis of cancer are available. Case Report: A 62-year-old woman with a history of breast cancer presented with right thigh pain after she had a fall. Radiographs indicated a transverse fracture in the shaft of the right femur. She had been on zoledronate treatment for six years. Based on radiographic and histopathological findings, we concluded that the fracture was not a pathological fracture associated with metastasis but was a complication of long-term BP treatment. Conclusion: Clinical oncologists should consider the possibility of BRAFs in patients on long-term zoledronate treatment for bone metastases.

• 出版日期2014-3